)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
LeonaBio
LeonaBio (LONA) investor relations material
LeonaBio 12th Annual Cantor Fitzgerald Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.12th Annual Cantor Fitzgerald Global Healthcare Conference summary11 Sep, 2026
Company overview and strategic focus
Recently established, focused on developing lasofoxifene, a unique SERM for metastatic breast cancer.
Raised $246 million and is led by experienced management and investors.
Emphasizes collaboration and aims to become the partner of choice in second-line metastatic breast cancer.
Lasofoxifene development and differentiation
Lasofoxifene is a potent SERM, showing superior activity against ESR1-mutated breast cancer compared to SERDs.
Demonstrates high affinity for mutated estrogen receptors, inactivating them without degrading healthy receptors.
Offers quality-of-life benefits by avoiding antagonism of estrogen receptors in non-breast tissues.
Clinical trial landscape and ELAINE program
ELAINE-1 and ELAINE-2 trials showed promising efficacy and safety, with no significant thrombotic events.
ELAINE-3 is a 600-patient, fully enriched ESR1 mutation trial comparing lasofoxifene-abemaciclib to fulvestrant-abemaciclib.
The trial is powered to detect a clinically meaningful PFS difference, aiming for double-digit months.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from LeonaBio
- Net loss rose to $52.0M as cash fell to $51.1M, with urgent need for additional funding.LONA
Q2 2026 - All proposals passed, directors reelected, and no shareholder questions were raised.LONAAGM 2026
- Virtual annual meeting to vote on directors, auditor, and executive pay, all board-recommended.LONAProxy filing
- Proxy covers director elections, auditor ratification, compensation, and ESG oversight.LONAProxy filing
- Q1 2026 net loss rose to $32.9M as R&D spending increased; cash covers 12 months, more funding needed.LONAQ1 2026
- Lasofoxifene plus abemaciclib shows strong promise for ESR1-mutated metastatic breast cancer.LONAStatus update
- Registering 5.5M shares for resale; proceeds from warrant exercise support drug pipeline.LONARegistration filing
- 58.5M shares registered for resale; warrant exercises could yield over $146M for clinical programs.LONARegistration filing
- Secured lasofoxifene license, raised $90M, and advanced clinical pipeline amid higher R&D spend.LONAQ4 2025
Next LeonaBio earnings date
Q3 20266 Nov, 2026
LeonaBio
Next LeonaBio earnings date
Q3 20266 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage